Net Cash Provided by (Used in) Financing Activities of Avid Bioservices, Inc. from 30 Apr 2010 to 31 Jul 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary: Avid Bioservices, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Apr 2010 to 31 Jul 2024.
Avid Bioservices, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Jul 2024 was $266,000, a 64% decline year-over-year.
Avid Bioservices, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $20,067,000, a 592% increase from 2022.
Avid Bioservices, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2,901,000, a 9.3% decline from 2021.
Avid Bioservices, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3,197,000, a 97% decline from 2020.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Financing Activities, Annual (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Avid Bioservices, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$266,000	-$482,000	-64%	01 May 2024	31 Jul 2024	10-Q	09 Sep 2024	2025	Q1
Q2 2023	$748,000	-$181,000	-19%	01 May 2023	31 Jul 2023	10-Q	09 Sep 2024	2025	Q1
Q2 2022	$929,000	+$11,000	+1.2%	01 May 2022	31 Jul 2022	10-Q/A	24 Apr 2024	2024	Q1
Q2 2021	$918,000	+$6,207,000		01 May 2021	31 Jul 2021	10-Q	06 Sep 2022	2023	Q1
Q2 2020	$5,289,000	-$4,388,000	-487%	01 May 2020	31 Jul 2020	10-Q	08 Sep 2021	2021	Q1
Q2 2019	$901,000	-$760,000	-539%	01 May 2019	31 Jul 2019	10-Q	01 Sep 2020	2021	Q1
Q2 2018	$141,000	-$3,211,000	-105%	01 May 2018	31 Jul 2018	10-Q	05 Sep 2019	2020	Q1
Q2 2017	$3,070,000	+$1,990,000	+184%	01 May 2017	31 Jul 2017	10-Q	10 Sep 2018	2019	Q1
Q2 2016	$1,080,000			01 May 2016	31 Jul 2016	10-Q	11 Sep 2017	2018	Q1
Q2 2013	$14,770,000	+$13,346,000	+937%	01 May 2013	31 Jul 2013	10-Q	09 Sep 2013	2014	Q1
Q2 2012	$1,424,000	-$1,644,000	-54%	01 May 2012	31 Jul 2012	10-Q	09 Sep 2013	2014	Q1
Q2 2011	$3,068,000	-$2,789,000	-48%	01 May 2011	31 Jul 2011	10-Q	10 Sep 2012	2013	Q1
Q2 2010	$5,857,000			01 May 2010	31 Jul 2010	10-Q	09 Sep 2011	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$20,067,000	+$17,166,000	+592%	01 May 2023	30 Apr 2024	10-K	02 Jul 2024	2024	FY
2022	$2,901,000	-$296,000	-9.3%	01 May 2022	30 Apr 2023	10-K	02 Jul 2024	2024	FY
2021	$3,197,000	-$109,138,000	-97%	01 May 2021	30 Apr 2022	10-K	02 Jul 2024	2024	FY
2020	$112,335,000	+$111,239,000	+10150%	01 May 2020	30 Apr 2021	10-K/A	24 Apr 2024	2023	FY
2019	$1,096,000	+$3,959,000		01 May 2019	30 Apr 2020	10-K	29 Jun 2022	2022	FY
2018	$2,863,000	-$25,114,000	-113%	01 May 2018	30 Apr 2019	10-K	29 Jun 2021	2021	FY
2017	$22,251,000	-$5,914,000	-21%	01 May 2017	30 Apr 2018	10-K	30 Jun 2020	2020	FY
2016	$28,165,000	-$13,628,000	-33%	01 May 2016	30 Apr 2017	10-K	27 Jun 2019	2019	FY
2015	$41,793,000			01 May 2015	30 Apr 2016	10-K	16 Jul 2018	2018	FY
2012	$38,848,000	+$6,841,000	+21%	01 May 2012	30 Apr 2013	10-K	11 Jul 2013	2013	FY
2011	$32,007,000	+$804,000	+2.6%	01 May 2011	30 Apr 2012	10-K	11 Jul 2013	2013	FY
2010	$31,203,000	+$7,311,000	+31%	01 May 2010	30 Apr 2011	10-K	11 Jul 2013	2013	FY
2009	$23,892,000			01 May 2009	30 Apr 2010	10-K	16 Jul 2012	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.